In this special episode, host Julie Rovner, KFF Health News’ chief Washington correspondent, interviews three noted health policy experts.
Patent thicket strategy with terminal disclaimers helps block biologic competition, JAMA letter shows
Biologics developers are protecting their most lucrative assets with a particular type of patent that they can quickly pile up and drive costly litigation around,